+ business and client orientated, i like working in a scientific environment, which includes learning and development opportunities. currently, this environment enables me to apply my scientific and management competences in the drug-market -access matter. + over the years i have acquired an expertise in general pharmacology related to Diabetes and metabolic diseases, oncology and Hematology, with a special focus in bacterial Infectious diseases: set up for a team of a new Research pathway within the field of anti-infective pharmacology. this provided answers with innovative in-vitro cellular models upcoming questions related to potential effects of transporters on antibiotics: (i) cellular Pharmacokinetics parameters. (ii) pharmacodynamic profile towards intracellular infection. (iii) toxicodynamic potential on Bacteria-infected cells. + self-motivated team player, focused and quick learner with a good oral and written Communication ability. + solid experience in (bio)analytical development and Validation methods for both Small molecules and Proteins. + demonstrated technical and Problem-solving skills with a significant of scientific accomplishments: 7 published papers on peer-reviewed journals and 12 communications. prix de la fondation belge de la vocation (f.b.v), fellowship isap (international society of applied pharmacology) to attend toronto iccac . specialties: transporters (influx/efflux) and drug drug interactions (ddis). characterisation of Preclinical admet drugs properties. antibiotics, intracellular infections, expertise in culturing cellular processes pharmacokinetic, pharmacodynamic,toxicodynamic drugs transporters mediated resistance mechanisms
Expert for the Belgian Medicine Reimbursement Committee at National Institute for Health& Disability
Since January 2011
evaluator in drug-Market access (Reimbursement procedure) for the "commission de remboursement des médicaments" with a focus in Diabetes, metabolic diseases, oncology, Hematology and Infectious diseases and special interest in hta (Health technology assessment). Evaluator in drug-market access (reimbursement procedure) for the "Commission de Remboursement des Médicaments" with a focus in diabetes, metabolic diseases, oncology, hematology and infectious diseases and special interest in HTA (Health Technology Assessment).
Project and team management in Biotechnology (FOREM Biotechnology training center, GIGA, Liège)September 2010 --- December 2010
Conception and redaction of a business plan to set-up a firm related to health products & allergyJanuary 2008 --- January 2010
Researcher Pharmacist - Project Manager in anti-infective pharmacologyJanuary 2000 --- January 2007
plan, conduct & supervise a project in a small Research team :cellular & Molecular Pharmacology unit (facm), ucl. prof. tulkens. assessment of drug transporters effects on pharmacokinetic, pharmacodynamic and toxicodynamic properties of anti-infective drugs belonging to several antibiotic families. characterisation of drugs properties either in Preclinical or Clinical Development. inclusion in Project Management boards to support R&D and Preclinical efforts for Pharmaceutical companies (lilly, bayer). experience of Education and formation: • Teaching in normal & special pharmacology. • Tutor and train technicians, undergraduate students and graduate researchers. • workshops design, presentation and animation for post-University Pharmacists. Analysis of results, writing of projects and Research reports ( 5 peer-reviewed papers and 8 communications).
Junior research investigatorJanuary 1998 --- January 2000
provide Leadership and strategic vision for the set up of a new Research activity in anti-infective pharmacology: • project initiation and implementation. redaction and submission of a Research project for granting processes: • bayer (100.keuros) and ucl (100.keuros). • writing of 1 peer-reviewed paper & 4 communications .
LinkedIn Assessment :
Training in biotechnology project and team management (GIGA Biotechnology training center, Liège). in from Université de Liège in 2011
Special degree in business management in Economie Sociale from Université libre de Bruxelles in 2009
PhD - Cellular and Molecular Pharmacology - GD - in Infectiology - PK/PD/TD - Development and validation of bacteria-(un)infected in-vitro models from Université catholique de Louvain in 2007
Complementary Master in Pharmaceutical Sciences - GD - in Pharmacology, Infectiology, eukaryotic in-vitro models from Université catholique de Louvain in 2000
PharmD in Epreuves du grade de Pharmacien - D - from Université catholique de Louvain in 1997
Area / Region
Walhain-Saint-Paul, Walhain, Belgium